Ensysce Biosciences, Inc. (ENSC) Net income 2018–2025
Ensysce Biosciences, Inc. (ENSC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.2MFY2025 · since FY2018: $2.1M → -$10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.2M | -27.4% |
| FY2024 | -$8.0M | +24.8% |
| FY2023 | -$10.6M | +56.1% |
| FY2022 | -$24.2M | +16.9% |
| FY2021 | -$29.1M | -776.1% |
| FY2020 | $4.3M | +503.9% |
| FY2019 | -$1.1M | -150.3% |
| FY2018 | $2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENSC financial trends
ENSC RevenueENSC Net marginENSC Gross profitENSC Gross marginENSC Operating incomeENSC Operating marginENSC Operating cash flowENSC Free cash flowENSC Capital expendituresENSC Return on equityENSC Stock buybacksENSC Dividends paidENSC Total assetsENSC Total liabilitiesENSC Shareholders’ equityENSC overview →